Detalles de la búsqueda
1.
A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall-cell lung cancer.
Int J Cancer
; 153(2): 364-372, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36916144
2.
Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer.
Curr Oncol Rep
; 24(1): 113-123, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35060001
3.
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(12): 1441-1464, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34902832
4.
Locally Advanced, Unresectable Non-Small Cell Lung Cancer.
Curr Oncol Rep
; 22(4): 31, 2020 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32140986
5.
Subcutaneous metastasis from recurrent basaloid squamous cell carcinoma of the esophagus.
J Oncol Pharm Pract
; 25(2): 492-496, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29078709
6.
Race-inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?
Cancer
; 129(23): 3692-3693, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37728029
7.
Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.
Curr Treat Options Oncol
; 19(8): 39, 2018 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29931587
8.
Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors.
Support Care Cancer
; 26(8): 2911-2918, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29546524
9.
Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
J Oncol Pharm Pract
; 22(3): 511-6, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25900102
10.
A matching-based machine learning approach to estimating optimal dynamic treatment regimes with time-to-event outcomes.
Stat Methods Med Res
; 33(5): 794-806, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502008
11.
Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSideTM.
Neurooncol Adv
; 6(1): vdad150, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38196737
12.
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial.
Nat Med
; 30(1): 265-270, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38177853
13.
Letter by Puri et al Regarding Article, "Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control".
Circulation
; 135(19): e1039-e1040, 2017 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28483838
14.
Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer.
Cancer Treat Res Commun
; 35: 100686, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736060
15.
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37586768
16.
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.
Clin Lung Cancer
; 24(7): e242-e246, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451930
17.
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
Lung Cancer
; 186: 107423, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37995456
18.
Systemic and Radiation Therapy Approaches for Locally Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 40(6): 576-585, 2022 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34985931
19.
Dynamic Prediction of Near-Term Overall Survival in Patients with Advanced NSCLC Based on Real-World Data.
Cancers (Basel)
; 14(3)2022 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158958
20.
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern.
JTO Clin Res Rep
; 3(3): 100280, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243411